Published in Am J Physiol Regul Integr Comp Physiol on April 03, 2013
Mitochondrial KATP channel involvement in angiotensin II-induced autophagy in vascular smooth muscle cells. Basic Res Cardiol (2014) 0.86
Prenatal inflammation-induced NF-κB dyshomeostasis contributes to renin-angiotensin system over-activity resulting in prenatally programmed hypertension in offspring. Sci Rep (2016) 0.84
Synergistic effects of high blood cholesterol and hypertension on leukocyte and platelet recruitment in the cerebral microcirculation. Hypertension (2013) 0.82
Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration. Free Radic Biol Med (2014) 0.81
Evaluation of Eu(II) -based positive contrast enhancement after intravenous, intraperitoneal, and subcutaneous injections. Contrast Media Mol Imaging (2016) 0.80
Oxidative stress causes imbalance of renal renin angiotensin system (RAS) components and hypertension in obese Zucker rats. J Am Heart Assoc (2015) 0.79
Upregulation of sestrin-2 expression protects against endothelial toxicity of angiotensin II. Cell Biol Toxicol (2014) 0.78
SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature. J Control Release (2015) 0.76
Ascorbic Acid Protects against Hypertension through Downregulation of ACE1 Gene Expression Mediated by Histone Deacetylation in Prenatal Inflammation-Induced Offspring. Sci Rep (2016) 0.75
Hydrogen Peroxide-Responsive Nanoparticle Reduces Myocardial Ischemia/Reperfusion Injury. J Am Heart Assoc (2016) 0.75
Post-Natal Inhibition of NF-κB Activation Prevents Renal Damage Caused by Prenatal LPS Exposure. PLoS One (2016) 0.75
Molecular Signature of Nitroso-Redox Balance in Idiopathic Dilated Cardiomyopathies. J Am Heart Assoc (2015) 0.75
Protective effect of a fish egg homogenate marine compound on arterial ultrastructure in spontaneous hypertensive rats. Rejuvenation Res (2014) 0.75
Defining the roles of arrestin2 and arrestin3 in vasoconstrictor receptor desensitization in hypertension. Am J Physiol Cell Physiol (2015) 0.75
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet (1996) 6.48
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest (1996) 6.38
Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37
Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet (2003) 5.34
Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med (1992) 5.31
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 5.09
Treatment of hypertension with ascorbic acid. Lancet (1999) 4.74
Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res (2007) 4.48
Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res (2004) 4.12
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res (2002) 3.29
Carotenoids and human health. Pharmacol Res (2007) 3.07
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med (2007) 2.69
Blood clearance rates of adenovirus type 5 in mice. J Gen Virol (2000) 2.36
Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension (2000) 2.30
Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res (2010) 2.28
Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system. Endocrinology (2003) 2.21
Beta-carotene and other carotenoids as antioxidants. J Am Coll Nutr (1999) 2.21
Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res (2006) 2.18
Inflammation in hypertension. Curr Opin Nephrol Hypertens (2006) 2.01
In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles. Nat Mater (2007) 1.99
Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem (1988) 1.98
Oxidative stress and hypertension. Med Clin North Am (2009) 1.95
Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther (2006) 1.93
Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol (2007) 1.88
Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med (2005) 1.87
ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management. Drug Saf (1996) 1.78
Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol (2010) 1.78
Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbits with pacing-induced chronic heart failure. Circulation (2007) 1.77
Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst (2002) 1.77
Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits. Cardiovasc Res (2008) 1.75
Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res (2004) 1.74
Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease. Braz J Med Biol Res (2004) 1.70
Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction. Cardiovasc Drugs Ther (2008) 1.63
Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes (2011) 1.61
Elevated mitochondrial superoxide contributes to enhanced chemoreflex in heart failure rabbits. Am J Physiol Regul Integr Comp Physiol (2009) 1.58
Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol (1996) 1.57
NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits. Cardiovasc Res (2007) 1.56
Redox signaling, vascular function, and hypertension. Antioxid Redox Signal (2008) 1.52
Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int (2000) 1.52
Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med (Berl) (2001) 1.51
Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension (2005) 1.50
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol (1996) 1.50
Tempol selectively attenuates angiotensin II evoked vasoconstrictor responses in spontaneously hypertensive rats. J Hypertens (2002) 1.49
Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB. Cardiovasc Res (2008) 1.44
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care (2002) 1.40
Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension (2002) 1.40
Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr (2001) 1.39
Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res (2003) 1.37
Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Free Radic Biol Med (2011) 1.31
Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol (2003) 1.30
Targeting of superoxide dismutase and catalase to vascular endothelium. J Control Release (2001) 1.28
Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox Signal (2012) 1.27
Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J (2009) 1.26
Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. Bioconjug Chem (2005) 1.26
Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis (2011) 1.25
Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochim Biophys Acta (2011) 1.23
NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol (2011) 1.23
Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension (2008) 1.22
Catalase and glutathione peroxidase mimics. Biochem Pharmacol (2008) 1.19
Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation (2001) 1.19
Resveratrol: a cardioprotective substance. Ann N Y Acad Sci (2011) 1.18
Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin Pharmacol Toxicol (2011) 1.18
Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic Biol Med (2006) 1.18
Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur J Pharmacol (2011) 1.17
Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension (2005) 1.15
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Med (2012) 1.15
High-dose ascorbic acid infusion abolishes chronic vasoconstriction and restores resting leg blood flow in healthy older men. J Appl Physiol (1985) (2007) 1.14
Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current. Am J Physiol Cell Physiol (2010) 1.14
Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. Adv Drug Deliv Rev (2002) 1.14
Protective effect of lycopene on serum cholesterol and blood pressure: Meta-analyses of intervention trials. Maturitas (2010) 1.13
Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med (2011) 1.11
PECAM-targeted delivery of SOD inhibits endothelial inflammatory response. FASEB J (2010) 1.11
Platelet-endothelial cell adhesion molecule-1-directed endothelial targeting of superoxide dismutase alleviates oxidative stress caused by either extracellular or intracellular superoxide. J Pharmacol Exp Ther (2007) 1.10
Antioxidants in hypertension and cardiovascular disease. Mol Interv (2010) 1.08
Catalase and superoxide dismutase conjugated with platelet-endothelial cell adhesion molecule antibody distinctly alleviate abnormal endothelial permeability caused by exogenous reactive oxygen species and vascular endothelial growth factor. J Pharmacol Exp Ther (2011) 1.07
Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study. Eur J Heart Fail (2012) 1.07
Stretch-induced injury of cultured neuronal, glial, and endothelial cells. Effect of polyethylene glycol-conjugated superoxide dismutase. Stroke (1996) 1.06
Modulation of the inflammatory response in cardiovascular disease. Hypertension (2004) 1.06
Current topic: the uteroplacental renin-angiotensin system. Placenta (2000) 1.05
Hypertension, nitric oxide, oxidants, and dietary plant polyphenols. Curr Pharm Biotechnol (2010) 1.05
The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase. Biomaterials (2010) 1.04
Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation (1998) 1.04
Astaxanthin, oxidative stress, inflammation and cardiovascular disease. Future Cardiol (2009) 1.04
Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects. J Investig Med (2007) 1.04
Gene therapy in the CNS. Gene Ther (2000) 1.04
The central nervous system and inflammation in hypertension. Curr Opin Pharmacol (2010) 1.03
Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction. Am J Physiol Regul Integr Comp Physiol (2008) 1.02
Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol (2001) 1.02
Transport across the blood-brain barrier of pluronic leptin. J Pharmacol Exp Ther (2010) 1.01
Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade. Hypertension (2010) 1.01
Modulation of delayed rectifier potassium current by angiotensin II in CATH.a cells. Biochem Biophys Res Commun (2003) 1.01
Resveratrol in cardiovascular disease: what is known from current research? Heart Fail Rev (2012) 1.01
Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats. Clin Exp Hypertens (2006) 1.01
Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons. Free Radic Biol Med (2010) 1.01
Vitamin E can reduce blood pressure in mild hypertensives. Int J Vitam Nutr Res (2002) 1.00
Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery. Bioconjug Chem (2008) 0.99
Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep (2000) 0.99
Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury. Curr Opin Nephrol Hypertens (2008) 0.99
A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell (2008) 6.16
Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits. Cardiovasc Res (2008) 1.75
Elevated mitochondrial superoxide contributes to enhanced chemoreflex in heart failure rabbits. Am J Physiol Regul Integr Comp Physiol (2009) 1.58
Role of gamma-glutamyl transpeptidase in redox regulation of K+ channel remodeling in postmyocardial infarction rat hearts. Am J Physiol Cell Physiol (2009) 1.45
A dysfunctional tricarboxylic acid cycle enhances fitness of Staphylococcus epidermidis during β-lactam stress. MBio (2013) 1.28
Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast. Free Radic Biol Med (2013) 1.23
Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current. Am J Physiol Cell Physiol (2010) 1.14
Exercise training prevents the exaggerated exercise pressor reflex in rats with chronic heart failure. J Appl Physiol (1985) (2010) 1.07
Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism. Am J Physiol Cell Physiol (2010) 1.05
The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase. Biomaterials (2010) 1.04
Acetyl-L-carnitine protects neuronal function from alcohol-induced oxidative damage in the brain. Free Radic Biol Med (2010) 1.02
Proline dehydrogenase is essential for proline protection against hydrogen peroxide-induced cell death. Free Radic Biol Med (2012) 1.02
Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons. Free Radic Biol Med (2010) 1.01
Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failure. Am J Physiol Heart Circ Physiol (2012) 1.01
Mitochondrial-localized NADPH oxidase 4 is a source of superoxide in angiotensin II-stimulated neurons. Am J Physiol Heart Circ Physiol (2013) 1.00
Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles. Nanomedicine (Lond) (2011) 0.99
Cross-linked antioxidant nanozymes for improved delivery to CNS. Nanomedicine (2011) 0.96
Mitochondrial dysfunction and mitochondrial-produced reactive oxygen species: new targets for neurogenic hypertension? Hypertension (2008) 0.96
Newborn lamb coronary artery reactivity is programmed by early gestation dexamethasone before the onset of systemic hypertension. Am J Physiol Regul Integr Comp Physiol (2005) 0.94
DNA release dynamics from reducible polyplexes by atomic force microscopy. Langmuir (2008) 0.88
Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation. Biomaterials (2011) 0.88
Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo. Mol Pharm (2012) 0.87
Objective assessment of functional ambulation in adults with hemiplegia using ankle foot orthotics after stroke. PM R (2009) 0.86
Endogenous reactive oxygen species modulates voltage-gated sodium channels in dorsal root ganglia of rats. J Appl Physiol (1985) (2011) 0.86
Effect of cell membrane thiols and reduction-triggered disassembly on transfection activity of bioreducible polyplexes. Eur J Pharm Sci (2012) 0.86
Intracellular siRNA and precursor miRNA trafficking using bioresponsive copolypeptides. J Gene Med (2008) 0.85
Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. Nanomedicine (Lond) (2013) 0.85
Smoke extract impairs adenosine wound healing: implications of smoke-generated reactive oxygen species. Am J Respir Cell Mol Biol (2013) 0.83
Effect of alcohol exposure on hepatic superoxide generation and hepcidin expression. World J Biol Chem (2013) 0.83
Angiotensin II, oxidant signaling, and hypertension: down to a T? Hypertension (2009) 0.80
The renin-angiotensin system in 2011: new avenues for translational research. Curr Opin Pharmacol (2011) 0.78
Evaluation of a dynamic ankle foot orthosis in hemiplegic gait: A case report. NeuroRehabilitation (2010) 0.77